Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2026
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 14, 2025
Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia.
Journal: British journal of haematology
Published: April 19, 2025
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 28, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.
Journal: Blood advances
Published: March 28, 2025
Chimeric Antigen Receptor-T Cells in the Modern Era of Chronic Lymphocytic Leukemia Treatment.
Journal: Cancers
Published: November 28, 2024
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.
Journal: Blood
Published: September 05, 2024
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
Journal: Blood
Published: December 05, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia.
Journal: Case reports in hematology
Published: November 09, 2021
Last Updated: 09/26/2026